FSA FINES AND BANS BROKERS

LONDON - The UK Financial Services Authority (FSA) says it has banned and fined broker Mohammed Suba Miah £21,000 for dishonesty and misleading customers. Miah worked at stockbroker Square Mile, which was recently fined £250,000 for persistent high-pressure sales tactics and providing misleading information. The regulator also acted to ban two partners from another mortgage broker for submitting false mortgage applications.

Amjad Malik and Tahir Mahmood, at Essex-based firm Abbaci Associates, submitted false information on clients' occupations and incomes. The FSA reviewed 19 transactions by Miah at Square Mile between December 2005 and May 2006. The frauds at Abbaci took place between October 2004 and October 2007, when the firm agreed to cease trading at the FSA's request.

The FSA found in 11 of Miah's cases he had dishonestly recorded the purchase of high-risk shares by customers without permissions. The first customers would have known about the trades would have been demands sent for payment. Miah is also said to have lied about the value and performance of shares and failed to inform customers of the higher risks involved in buying them. The FSA said Miah's case was particularly serious because of the position of trust and that customers were exposed to significant risk of financial loss. It is the first time the FSA has issued both a fine and ban against an approved individual.

The FSA described its actions as part of wider efforts to tackle mortgage fraud, in addition to its concentrated efforts against financial crime, and for consumer and market confidence - outlined in its Financial Risk Outlook (FRO) and budget in the last month.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here